The standard of care for managing patients with type 2 diabetes and CKD -- in addition to a healthy lifestyle -- has always ...

Angiotensin II and other components of the renin–angiotensin–aldosterone system (RAAS ... the titration of ACE inhibitor dose against urinary protein excretion together with the use of ...

The renin–angiotensin–aldosterone system (RAAS) is implicated in the ... Secondary outcomes included the rates of change in urinary aldosterone and albumin excretion, frequency of ...

Despite the high urinary potassium concentration ... disturbances that originate at any point in the renin–angiotensin–aldosterone system. Such disturbances can result from a disease state ...

PHILADELPHIA — The use of dual renin-angiotensin-aldosterone system (RAAS ... with a reduction in "left ventricular mass index, urinary albumin excretion, and renal vascular resistance." ...

ZENITH-CKD is the first randomized trial comparing combined SGLT2 and endothelin A inhibition in patients with chronic kidney disease. Zibotentan, a selective endothelin A receptor antagonist, may ...

Unique Characteristics of Hypertension in Blacks That Influence BP Responses to Drugs That Block the Renin-Angiotensin Activating System (RAAS) Blockade of the RAAS in Blacks for Cardiovascular ...

heart failure or other conditions treated with renin–angiotensin–aldosterone system (RAAS) inhibitors, and has been associated with severe adverse outcomes, including death. The risk of chronic ...

A sick child taking medication Real-world data on use of RAAS inhibitors can be used to support future pragmatic studies to optimize management of childhood-onset SLE, according to investigators.